Apyx Medical Corp Deferred State and Local Income Tax Expense (Benefit)
Apyx Medical Corp (APYX) reported Deferred State and Local Income Tax Expense (Benefit) of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit · last filed 2026-03-10
- Apyx Medical Corp deferred state and local income tax expense (benefit) for fiscal 2025 was $0.00.
- Apyx Medical Corp deferred state and local income tax expense (benefit) for fiscal 2024 was $0.00.
- Apyx Medical Corp deferred state and local income tax expense (benefit) for fiscal 2023 was -$989.00K.
- Apyx Medical Corp deferred state and local income tax expense (benefit) for fiscal 2022 was -$1.00M.
| Period end | Deferred State and Local Income Tax Expense (Benefit) 12 month | Deferred State and Local Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-10 | |
| 2024-12-31 | $0.00 10-K · filed 2026-03-10 | -$585.00K 10-K · filed 2025-03-13 |
| 2023-12-31 | -$989.00K 10-K · filed 2025-03-13 | |
| 2022-12-31 | -$1.00M 10-K · filed 2024-03-21 | |
| 2021-12-31 | -$613.00K 10-K · filed 2023-03-16 | |
| 2020-12-31 | -$1.00M 10-K · filed 2022-03-17 | |
| 2019-12-31 | -$741.00K 10-K · filed 2021-03-31 | |
| 2018-12-31 | $7.00K 10-K · filed 2020-03-31 | $63.00K 10-K · filed 2019-03-14 |
| 2017-12-31 | -$401.00K 10-K · filed 2020-03-31 | |
| 2016-12-31 | -$277.00K 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |